PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
Karam Al-Halabi(Heidelberg University), Christine Haberler(Medical University of Vienna), Matthias A. Karajannis(NYU Langone Health), Adam Levy(Children's Hospital at Montefiore), Damian Stichel(German Cancer Research Center), Christof M. Kramm(Universitätsmedizin Göttingen), Catherine Godfraind(Centre Hospitalier Universitaire de Toulouse), Lenka Krsková(Charles University), Dominik Sturm(German Cancer Research Center), Till Acker(Friedrich-Alexander-Universität Erlangen-Nürnberg), Nicholas G. Gottardo(St Nicholas Hospital), Ingrid Øra(Karolinska University Hospital), Heike Peterziel(German Cancer Research Center), Nancy Bouvier(University of California, San Francisco), Jordan R. Hansford, Maria Filippidou(German Cancer Research Center), Bastiaan B.J. Tops(Radboud University Nijmegen), Chris Jones(North Carolina State University), Torben Stamm Mikkelsen(Aarhus University Hospital), Lidija Kitanovski(Ljubljana University Medical Centre), Evelina Miele(Bambino Gesù Children's Hospital), Alexander C. Sommerkamp(German Cancer Research Center), Johannes Gojo(Medical University of Vienna), Mariëtte E.G. Kranendonk(Princess Máxima Center), Allison Martin(Albert Einstein College of Medicine), Michal Zápotocký(Charles University), David Sumerauer(Charles University), Philipp Sievers(German Cancer Research Center), Torsten Pietsch(University Hospital Bonn), Pieter Wesseling(Radboud University Nijmegen), Simone Schmid(Humboldt-Universität zu Berlin), Antonis Kattamis, Pengbo Beck(German Cancer Research Center), Katharina Filipski(Goethe University Frankfurt), Nagma Dalvi(Albert Einstein College of Medicine), George Jour(New York University), Emmanuelle Uro‐Coste(Institut universitaire du cancer de Toulouse Oncopole), Katja von Hoff(Universität Hamburg), Elli Papaemmanuil(Memorial Sloan Kettering Cancer Center), Matija Snuderl, Fanny Burel‐Vandenbos, Michael DeLorenzo(NYU Langone Health), Martin Sill(German Cancer Research Center), David Scheie(Copenhagen University Hospital), Natalie Jäger(German Cancer Research Center), Andrea Wittmann(German Cancer Research Center), Hildegard Dohmen(Justus-Liebig-Universität Gießen), Kristian W. Pajtler(German Cancer Research Center), Claude-Alain Maurage(Inserm), Martin G. McCabe(Manchester Academic Health Science Centre)
Cited by 83
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k